A Study of the Safety and Effectiveness of Different Doses of 1592U89 in HIV-Infected Patients

The Safety and Effects of 1592U89 Used Alone or in Combination With Other Anti-HIV Drugs in HIV-Infected Infants and Children

NCT00000865 ·Status: COMPLETED ·Phase: PHASE1

Evaluation of Safety, Tolerability, Pharmacokinetics, and Antiretroviral Activity of Ulonivirine (MK-8507) in Human Immunodeficiency Virus (HIV-1)-Infected Participants (MK-8507-003)

NCT02174159 ·Status: COMPLETED ·Phase: PHASE1

Comparison of GW433908 and Nelfinavir in HIV Patients Who Have Not Had Antiretroviral Therapy

NCT00008554 ·Status: UNKNOWN ·Phase: PHASE3

Study to Evaluate the Safety and Efficacy of Bictegravir/Emtricitabine/Tenofovir Alafenamide Versus Abacavir/Dolutegravir/Lamivudine in Human Immunodeficiency Virus-1 (HIV-1) Infected, Antiretroviral Treatment-Naive Adults

NCT02607930 ·Status: COMPLETED ·Phase: PHASE3

A Phase I Trial to Evaluate the Safety, Pharmacokinetics and Antiviral Activity of 141W94 After Multiple Dosing in Patients With HIV Infection

NCT00002183 ·Status: COMPLETED ·Phase: PHASE1

Mycophenolate Mofetil and Abacavir Treatment in HIV Patients With Failed Anti-HIV Treatment

NCT00021489 ·Status: WITHDRAWN ·Phase: PHASE2

Dual Therapy in HIV Patients in 4 Days a Week Versus 7 Days a Week

NCT04867083 ·Status: UNKNOWN ·Phase: PHASE3

To Investigate the Safety and Efficacy of UB-421 Monotherapy in HIV Infected Adults

NCT02369146 ·Status: COMPLETED ·Phase: PHASE2

Study to Evaluate the Safety and Efficacy of Switching From Regimens Consisting of Boosted Atazanavir or Darunavir Plus Either Emtricitabine/Tenofovir or Abacavir/Lamivudine to Bictegravir/Emtricitabine/Tenofovir Alafenamide in Virologically Suppressed HIV-1 Infected Adults

NCT02603107 ·Status: COMPLETED ·Phase: PHASE3

A Phase III Randomized Double-Blind, Multicenter Study to Evaluate the Safety and Efficacy of 3TC/ZDV/1592U89 and 3TC/ZDV/IDV in HIV-1 Infected Antiretroviral Therapy-Naive Subjects.

NCT00002199 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate the Pharmacokinetics, Safety, Tolerability, and Antiviral Activity of Rilpivirine (TMC278) in Human Immunodeficiency Virus Infected Adolescents and Children Aged Greater Than or Equal to 6 Years

NCT00799864 ·Status: COMPLETED ·Phase: PHASE2

A Dose Ranging Study Of GW640385 Boosted With Ritonavir (Rtv) In Comparison To A RTV-Boosted Protease Inhibitor (PI) In HIV-1 Infected PI-Experienced Adults

NCT00242879 ·Status: TERMINATED ·Phase: PHASE2

A Study to Evaluate the Safety and Efficacy of Raltegravir (MK0518) in HIV-Infected Patients Failing Current Antiretroviral Therapies (0518-019)

NCT00293254 ·Status: COMPLETED ·Phase: PHASE3

Study of GS-3242 in Participants With HIV-1; Substudy-05

NCT07001319 ·Status: COMPLETED ·Phase: PHASE1

A Study of the Safety and Effectiveness of Combination Anti-HIV Therapy in HIV-Infected Adults

NCT00004585 ·Status: COMPLETED ·Phase: PHASE4

A Study of Saquinavir Used Alone or in Combination With Other Anti-HIV Drugs in HIV-Infected Patients

NCT00002382 ·Status: COMPLETED ·Phase: PHASE3

Study to Evaluate Safety, Pharmacokinetics, and Antiviral Activity of Bictegravir (GS-9883) in Human Immunodeficiency Virus (HIV)-1 Infected Participants

NCT02275065 ·Status: COMPLETED ·Phase: PHASE1

Safety and Effectiveness of Giving Adefovir Dipivoxil Plus Abacavir Plus Efavirenz Plus Amprenavir to HIV-Infected Patients Who Have Failed to Respond to Previous Protease Inhibitor Treatment

NCT00002419 ·Status: COMPLETED ·Phase: PHASE2

Five-Drug Anti-HIV Treatment Followed by Treatment Interruption in Patients Who Have Recently Been Infected With HIV

NCT00000940 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate the Efficacy, Safety, and Tolerability of Using an Oral Once-daily 2 Drug Regimen Compared to an Oral Once-daily 3 Drug Regimen for the Treatment of Human Immunodeficiency Virus (HIV)-1 in Adults Who Have Not Previously Taken Antiretroviral Therapy

NCT05979311 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

MK-8510 Monotherapy for the Treatment of Anti-retroviral naïve Human Immunodeficiency Virus Type 1 (HIV-1) Infected Participants (MK-8510-002)

NCT05700734 ·Status: WITHDRAWN ·Phase: PHASE1

A Study of the Safety, Pharmacokinetics and Antiretroviral Activity of 10-1074

NCT02511990 ·Status: COMPLETED ·Phase: PHASE1

A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Etravirine Administered in Combination With Other Antiretroviral Agents in Antiretroviral Treatment-Experienced HIV-1 Infected Patients

NCT01422330 ·Status: COMPLETED ·Phase: PHASE4

A Study Comparing The Safety, Tolerability and Efficacy of Trizivir VS Combivir & Atazanavir In Subjects With HIV

NCT00082394 ·Status: COMPLETED ·Phase: PHASE4

Safety and Effectiveness of Tenofovir Disoproxil Fumarate (Tenofovir DF) Plus Other Anti-HIV Drugs in HIV-Infected Patients

NCT00002450 ·Status: COMPLETED ·Phase: PHASE3